Loading Page
Dr. Justine Muriel Kahn, MD is a physician provider in New York, NY specializing in physician, pediatric hematology and general pediatrics. Dr. Justine Muriel Kahn, MD is affiliated with NewYork-Presbyterian, ColumbiaDoctors and CUIMC/Herbert Irving Pavilion.
She completed residency at Mount Sinai Medical Center. She is certified by the Board Certification: pediatrics and has a state license in New York.
Residency: Mount Sinai Medical Center
Board Certification: Board Certification: pediatrics
Licensed In: New York
Dr. Justine Muriel Kahn, MD appears to accept the following insurance providers: Emblem/GHI, Emblem/Hip, MVP Health Care, WellCare, Multiplan, Healthspring (Cigna Medicare), AETNA, UnitedHealthcare, Affinity Health Plan, Magnacare (National), Medicare, CIGNA, Local 1199, Fidelis Care, Healthfirst, Empire Blue Cross Blue Shield Healthplus, VNSNY CHOICE, World Trade Center Health Plan, ElderServe, Amida Care, GHI PPO, CIGNA PPO, CIGNA POS, Aetna Signature Administrators, Blue Shield PPO, CIGNA HMO, CIGNA EPO, Blue Shield HMO, Blue Shield EPO, Medicaid Managed Care, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Railroad Medicare, Aetna POS, Vytra, United Healthcare, HIP EPO, Great-West Healthcare, Medicaid, Oxford HMO, Empire BlueCross BlueShield HMO, HIP PPO, HIP POS, HIP HMO, Empire BlueCross BlueShield PPO, Aetna EPO, Aetna PPO, Aetna HMO, Medicare - Traditional Medicare, VNSNY CHOICE - Medicare Managed Care, World Trade Center Health Plan - World Trade Center Health Plan, Healthfirst - Child/Family Health Plus, Healthfirst - Leaf (Exchange), AETNA - Medicare Managed Care, VNSNY CHOICE - Special Needs, MVP Health Care - Essential Plan, AETNA - NY Signature, Empire Blue Cross - EPO, MVP Health Care - HMO, Healthfirst - Medicare Managed Care, AETNA - Student Health, Amida Care - Special Needs, MVP Health Care - Child/Family Health Plus, VNSNY CHOICE - SelectHealth and ElderServe - Special Needs.
According to our sources, Dr. Justine Muriel Kahn, MD accepts the following insurance providers:
Dr. Justine Muriel Kahn, MD does not have any reviews yet, be the first to leave a review of Dr. Justine Muriel Kahn, MD here: Leave a Review
These charts describe general payments received by Dr. Justine Muriel Kahn, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$2,388
$2,388 |
|||
|
$1,262
KEYTRUDA $1,262 |
|||
|
$322
Defitelio $128 |
Erwinaze $91 |
$104 |
|
|
$80
Oncaspar $80 |
|||
|
$50
ASPARLAS $25 |
Oncaspar $25 |
||
|
$25
Oncaspar $25 |
| $2,388 | |
| $1,022 | |
| $717 |
Dr. Justine Muriel Kahn, MD has received 16 research payments totaling $304,030.
Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation. Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium.
